Hearing Loss Linked to Lower Odds of Employment, Lower Income
By Elana Gotkine HealthDay Reporter

THURSDAY, Aug. 7, 2025 -- Hearing loss is associated with a reduced likelihood of employment and with lower income among young adults, according to a study published online Aug. 1 in Frontiers in Audiology and Otology.
Molly Jacobs, Ph.D., from the University of Florida in Gainesville, and colleagues examined differences in employment and income among young adults with hearing loss, tinnitus, and both using data from waves IV and V of the National Longitudinal Study of Adolescent to Adult Health, including self-reported hearing loss for individuals aged 24 to 43 years.
The researchers found that 5.81 to 8.87 percent of respondents reported tinnitus only, 0.82 to 1.39 percent reported hearing loss only, and 0.54 to 1.41 percent reported both. Compared with White individuals, Black individuals were less likely to have paid employment and earned lower income (odds ratios [ORs], 0.72 and 0.85, respectively). No differences were seen in the likelihood of employment/income between those with tinnitus/both conditions versus those with no difficulties; the likelihood of paid employment and income were lower for those with hearing loss (ORs, 0.88 and 0.95, respectively). The likelihood of paid employment was lower for Black and Hispanic individuals with hearing loss (ORs, 0.02 and 0.01, respectively). Lower income was earned by Black individuals with hearing loss, tinnitus, and other respondents with both (ORs, 0.79, 0.83, and 0.72, respectively).
"We found that these detrimental effects are especially pronounced among Black and Hispanic individuals, who face additional barriers to employment and income," Jacobs said in a statement. "Our findings highlight how hearing health can shape early career outcomes and long-term financial stability."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-08 06:00
Read more

- Genentech Provides Update on Astegolimab in Chronic Obstructive Pulmonary Disease
- No Risks Seen With Early Childhood Exposure to Aluminum-Adsorbed Vaccines
- Millions of Backyard Pools Recalled After Drowning Deaths of Nine Children
- Most Major Ice Cream Brands Will Remove Synthetic Dyes by 2028
- Teen Tobacco Product Use Tied to Worse Mental Health
- Killer Whales Show a Softer Side, Sharing Food With People
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions